Report Overview
Report Overview
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
The global Hospital-acquired Infection Diagnostics market size was estimated at USD 5472.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.10% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Hospital-acquired Infection Diagnostics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Hospital-acquired Infection Diagnostics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Hospital-acquired Infection Diagnostics market.
Global Hospital-acquired Infection Diagnostics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Abbott Laboratories
Advan DX
Abbott
Astrazeneca PLC
Bayer Schering Pharma LLC
Becton Dickinson And Company
Cepheid Inc.
Roche AG
Daiichi Sankyo
Hologic, Inc.
Market Segmentation (by Type)
Instrument and Reagents
Consumables
Market Segmentation (by Application)
Hospital
Clinics
Ambulatory Surgery Centers (ASC)
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Hospital-acquired Infection Diagnostics Market
Overview of the regional outlook of the Hospital-acquired Infection Diagnostics Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hospital-acquired Infection Diagnostics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the markets competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porters five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Hospital-acquired Infection Diagnostics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Table of Contents
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Hospital-acquired Infection Diagnostics
- 1.2 Key Market Segments
- 1.2.1 Hospital-acquired Infection Diagnostics Segment by Type
- 1.2.2 Hospital-acquired Infection Diagnostics Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Hospital-acquired Infection Diagnostics Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Hospital-acquired Infection Diagnostics Market Size (M USD) Estimates and Forecasts (2020-2035)
- 2.1.2 Global Hospital-acquired Infection Diagnostics Sales Estimates and Forecasts (2020-2035)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 2.1 Global Market Overview
- 3 Hospital-acquired Infection Diagnostics Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Hospital-acquired Infection Diagnostics Product Life Cycle
- 3.3 Global Hospital-acquired Infection Diagnostics Sales by Manufacturers (2020-2025)
- 3.4 Global Hospital-acquired Infection Diagnostics Revenue Market Share by Manufacturers (2020-2025)
- 3.5 Hospital-acquired Infection Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Hospital-acquired Infection Diagnostics Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
- 3.8 Hospital-acquired Infection Diagnostics Market Competitive Situation and Trends
- 3.8.1 Hospital-acquired Infection Diagnostics Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest Hospital-acquired Infection Diagnostics Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Hospital-acquired Infection Diagnostics Industry Chain Analysis
- 4.1 Hospital-acquired Infection Diagnostics Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Hospital-acquired Infection Diagnostics Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Hospital-acquired Infection Diagnostics Market Porters Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions and Their Impacts to Hospital-acquired Infection Diagnostics Market
- 5.7 ESG Ratings of Leading Companies
- 6 Hospital-acquired Infection Diagnostics Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Hospital-acquired Infection Diagnostics Sales Market Share by Type (2020-2025)
- 6.3 Global Hospital-acquired Infection Diagnostics Market Size by Type (2020-2025)
- 6.4 Global Hospital-acquired Infection Diagnostics Price by Type (2020-2025)
- 7 Hospital-acquired Infection Diagnostics Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Hospital-acquired Infection Diagnostics Market Sales by Application (2020-2025)
- 7.3 Global Hospital-acquired Infection Diagnostics Market Size (M USD) by Application (2020-2025)
- 7.4 Global Hospital-acquired Infection Diagnostics Sales Growth Rate by Application (2020-2025)
- 8 Hospital-acquired Infection Diagnostics Market Sales by Region
- 8.1 Global Hospital-acquired Infection Diagnostics Sales by Region
- 8.1.1 Global Hospital-acquired Infection Diagnostics Sales by Region
- 8.1.2 Global Hospital-acquired Infection Diagnostics Sales Market Share by Region
- 8.2 Global Hospital-acquired Infection Diagnostics Market Size by Region
- 8.2.1 Global Hospital-acquired Infection Diagnostics Market Size by Region
- 8.2.2 Global Hospital-acquired Infection Diagnostics Market Size by Region
- 8.3 North America
- 8.3.1 North America Hospital-acquired Infection Diagnostics Sales by Country
- 8.3.2 North America Hospital-acquired Infection Diagnostics Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Hospital-acquired Infection Diagnostics Sales by Country
- 8.4.2 Europe Hospital-acquired Infection Diagnostics Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Hospital-acquired Infection Diagnostics Sales by Region
- 8.5.2 Asia Pacific Hospital-acquired Infection Diagnostics Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Hospital-acquired Infection Diagnostics Sales by Country
- 8.6.2 South America Hospital-acquired Infection Diagnostics Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa Hospital-acquired Infection Diagnostics Sales by Region
- 8.7.2 Middle East and Africa Hospital-acquired Infection Diagnostics Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 8.1 Global Hospital-acquired Infection Diagnostics Sales by Region
- 9 Hospital-acquired Infection Diagnostics Market Production by Region
- 9.1 Global Production of Hospital-acquired Infection Diagnostics by Region(2020-2025)
- 9.2 Global Hospital-acquired Infection Diagnostics Revenue Market Share by Region (2020-2025)
- 9.3 Global Hospital-acquired Infection Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America Hospital-acquired Infection Diagnostics Production
- 9.4.1 North America Hospital-acquired Infection Diagnostics Production Growth Rate (2020-2025)
- 9.4.2 North America Hospital-acquired Infection Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe Hospital-acquired Infection Diagnostics Production
- 9.5.1 Europe Hospital-acquired Infection Diagnostics Production Growth Rate (2020-2025)
- 9.5.2 Europe Hospital-acquired Infection Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan Hospital-acquired Infection Diagnostics Production (2020-2025)
- 9.6.1 Japan Hospital-acquired Infection Diagnostics Production Growth Rate (2020-2025)
- 9.6.2 Japan Hospital-acquired Infection Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China Hospital-acquired Infection Diagnostics Production (2020-2025)
- 9.7.1 China Hospital-acquired Infection Diagnostics Production Growth Rate (2020-2025)
- 9.7.2 China Hospital-acquired Infection Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Abbott Laboratories
- 10.1.1 Abbott Laboratories Basic Information
- 10.1.2 Abbott Laboratories Hospital-acquired Infection Diagnostics Product Overview
- 10.1.3 Abbott Laboratories Hospital-acquired Infection Diagnostics Product Market Performance
- 10.1.4 Abbott Laboratories Business Overview
- 10.1.5 Abbott Laboratories SWOT Analysis
- 10.1.6 Abbott Laboratories Recent Developments
- 10.2 Advan DX
- 10.2.1 Advan DX Basic Information
- 10.2.2 Advan DX Hospital-acquired Infection Diagnostics Product Overview
- 10.2.3 Advan DX Hospital-acquired Infection Diagnostics Product Market Performance
- 10.2.4 Advan DX Business Overview
- 10.2.5 Advan DX SWOT Analysis
- 10.2.6 Advan DX Recent Developments
- 10.3 Abbott
- 10.3.1 Abbott Basic Information
- 10.3.2 Abbott Hospital-acquired Infection Diagnostics Product Overview
- 10.3.3 Abbott Hospital-acquired Infection Diagnostics Product Market Performance
- 10.3.4 Abbott Business Overview
- 10.3.5 Abbott SWOT Analysis
- 10.3.6 Abbott Recent Developments
- 10.4 Astrazeneca PLC
- 10.4.1 Astrazeneca PLC Basic Information
- 10.4.2 Astrazeneca PLC Hospital-acquired Infection Diagnostics Product Overview
- 10.4.3 Astrazeneca PLC Hospital-acquired Infection Diagnostics Product Market Performance
- 10.4.4 Astrazeneca PLC Business Overview
- 10.4.5 Astrazeneca PLC Recent Developments
- 10.5 Bayer Schering Pharma LLC
- 10.5.1 Bayer Schering Pharma LLC Basic Information
- 10.5.2 Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Product Overview
- 10.5.3 Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Product Market Performance
- 10.5.4 Bayer Schering Pharma LLC Business Overview
- 10.5.5 Bayer Schering Pharma LLC Recent Developments
- 10.6 Becton Dickinson And Company
- 10.6.1 Becton Dickinson And Company Basic Information
- 10.6.2 Becton Dickinson And Company Hospital-acquired Infection Diagnostics Product Overview
- 10.6.3 Becton Dickinson And Company Hospital-acquired Infection Diagnostics Product Market Performance
- 10.6.4 Becton Dickinson And Company Business Overview
- 10.6.5 Becton Dickinson And Company Recent Developments
- 10.7 Cepheid Inc.
- 10.7.1 Cepheid Inc. Basic Information
- 10.7.2 Cepheid Inc. Hospital-acquired Infection Diagnostics Product Overview
- 10.7.3 Cepheid Inc. Hospital-acquired Infection Diagnostics Product Market Performance
- 10.7.4 Cepheid Inc. Business Overview
- 10.7.5 Cepheid Inc. Recent Developments
- 10.8 Roche AG
- 10.8.1 Roche AG Basic Information
- 10.8.2 Roche AG Hospital-acquired Infection Diagnostics Product Overview
- 10.8.3 Roche AG Hospital-acquired Infection Diagnostics Product Market Performance
- 10.8.4 Roche AG Business Overview
- 10.8.5 Roche AG Recent Developments
- 10.9 Daiichi Sankyo
- 10.9.1 Daiichi Sankyo Basic Information
- 10.9.2 Daiichi Sankyo Hospital-acquired Infection Diagnostics Product Overview
- 10.9.3 Daiichi Sankyo Hospital-acquired Infection Diagnostics Product Market Performance
- 10.9.4 Daiichi Sankyo Business Overview
- 10.9.5 Daiichi Sankyo Recent Developments
- 10.10 Hologic, Inc.
- 10.10.1 Hologic, Inc. Basic Information
- 10.10.2 Hologic, Inc. Hospital-acquired Infection Diagnostics Product Overview
- 10.10.3 Hologic, Inc. Hospital-acquired Infection Diagnostics Product Market Performance
- 10.10.4 Hologic, Inc. Business Overview
- 10.10.5 Hologic, Inc. Recent Developments
- 10.1 Abbott Laboratories
- 11 Hospital-acquired Infection Diagnostics Market Forecast by Region
- 11.1 Global Hospital-acquired Infection Diagnostics Market Size Forecast
- 11.2 Global Hospital-acquired Infection Diagnostics Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe Hospital-acquired Infection Diagnostics Market Size Forecast by Country
- 11.2.3 Asia Pacific Hospital-acquired Infection Diagnostics Market Size Forecast by Region
- 11.2.4 South America Hospital-acquired Infection Diagnostics Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of Hospital-acquired Infection Diagnostics by Country
- 12 Forecast Market by Type and by Application (2026-2035)
- 12.1 Global Hospital-acquired Infection Diagnostics Market Forecast by Type (2026-2035)
- 12.1.1 Global Forecasted Sales of Hospital-acquired Infection Diagnostics by Type (2026-2035)
- 12.1.2 Global Hospital-acquired Infection Diagnostics Market Size Forecast by Type (2026-2035)
- 12.1.3 Global Forecasted Price of Hospital-acquired Infection Diagnostics by Type (2026-2035)
- 12.2 Global Hospital-acquired Infection Diagnostics Market Forecast by Application (2026-2035)
- 12.2.1 Global Hospital-acquired Infection Diagnostics Sales (K Units) Forecast by Application
- 12.2.2 Global Hospital-acquired Infection Diagnostics Market Size (M USD) Forecast by Application (2026-2035)
- 12.1 Global Hospital-acquired Infection Diagnostics Market Forecast by Type (2026-2035)
- 13 Conclusion and Key Findings